Viscosupplementation Market Size
The global viscosupplementation market is expected to experience significant growth, reaching US$ 10.16 billion by 2033 from US$ 4.66 billion in 2024. This growth reflects a compound annual growth rate (CAGR) of 9.02% between 2025 and 2033. The key factors driving this expansion include the increasing prevalence of osteoarthritis (OA), aging populations, and a heightened awareness of non-invasive joint pain management treatments. Viscosupplementation, which involves injecting hyaluronic acid into joints to relieve pain and improve mobility, is gaining popularity as a preferred option for managing joint degeneration, further fueling market growth.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=viscosupplementation-market-p.php
Viscosupplementation Market Outlook
Viscosupplementation is a minimally invasive treatment that involves the injection of hyaluronic acid into affected joints to reduce pain and im